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Neural tube defects, maternal cohorts, and age:
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Abstract
The effects of maternal year of birth and age
on the declining prevalence of neural tube
defects after 1972-3 were examined using 403
cases ascertained in a prospective study in the
Fylde of Lancashire during 1957-89. Matched
case-control data were analysed using condi-
tional logistic regression analysis.
The risk of an anencephalic baby was
significantly greater for older mothers, but
changes in the maternal age distribution in the
population did not appear to be relevant to the
recent decline in prevalence. Antenatal
diagnosis and termination of pregnancy was
the major cause.
Mothers born before 1950 were at signifi-
cantly greater risk of producing a baby with
spina bifida or cranium bifidum. We suggest
that abandonment of mercury as a therapeutic
agent for infants in the early 1950s is a
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This paper examines the relationship between
year of maternal birth, maternal age, and the
prevalence of neural tube defects in the Fylde of
Lancashire, with particular reference to the
decline after 1972-3.
Janerich showed by cohort analysis that the
absolute risk of anencephaly was more directly
related to the mother's year of birth than to that
of the affected child.' This suggested that
environmental aetiological factors act early
in the mother's life affecting the risk of an-
encephalic offspring throughout her repro-
ductive period.
In the Fylde during 1957-76 the prevalence
of anencephaly fell suddenly and significantly
after 1968.2 The prevalence of spina bifida and
cranium bifidum also fell, but to a lesser extent.
Subsequently, after the early 1970s, both types
of neural tube defect declined.
In England and Wales the decline in pre-
valence of neural tube defects that began in
1972 was not explicable solely by prenatal
diagnosis and termination of pregnancy.3 In
Liverpool the decline from 1974 was more
noticeable for anencephaly than spina bifida.4
In Sheffield a dramatic decline in spina bifida
births was partly due to antenatal diagnosis and
termination, which was even more successful in
reducing anencephaly.5
We have sought to explain the underlying
decline by looking for a maternal age or cohort
effect and, if found, a cause.
Methods
Cases of neural tube defect were ascertained as
part of a prospective survey, described in detail
previously, of babies with major congenital
malformations born in the Fylde to residents
there during 1957-816 Data was collected daily
by one paediatrician and a very high rate of
necropsies was maintained. Recording of cases
was continued until the end of 1989. Termina-
tions of pregnancy for antenatal diagnosis of
neural tube defects were ascertained from the
local obstetricians' records.
The total numbers of cases, including
terminations, were 190 for anencephaly, 181 for
spina bifida cystica, and 32 for cranium bifidum
cysticum (excluding five early cases where the
mother's date of birth was not known). There
were 116 282 live births and stillbirths in the
33 years (1957-89).
The separation of the effects of maternal age
at birth of child, year of birth of the child (or
termination of the pregnancy), and year of birth
of the mother cannot be achieved using a
standard study design, as the date of birth of the
child (BC) is mathematically defined by the date
of birth of the mother (BM) and the age of
the mother (AM) through the relation
BC=BM+AM. The statistical problem in
separating the (maternal) age, (birth) period,
and (maternal) cohort effects has been discussed
by many authors.7 8 Plewis makes the point that
it is always possible to design a study to estimate
any two of these three effects, and gives several
study designs.9
In this study, we have adopted a matched
case-control approach; by controlling for year of
birth of the child then the effects of maternal
age and maternal year of birth may be separated
by suitable statistical techniques. This pro-
cedure allows us to seek an explanation for a
known temporal effect (the decrease in the rates
of anencephaly and of spina bifida and cranium
bifidum after the early 1970s).
Controls were obtained from birth records of
the consultant obstetric hospital, which served
all the Fylde. It was possible, therefore, to
match cases born outside the hospital with
controls from the same district. A single control
was used for each case, taking the first birth of a
normal baby for the same year and month which
matched for district of residence of the mother
and sex of the baby. The date of birth and parity
of the control mother was then recorded.
The statistical analysis of matched case-
control data using conditional logistic regression
analysis is described in Breslow and Day.'0
The statistical package GLIM is well suited
to fit such models and Adena and Wilson
describe a range of procedures." 12 We used
their procedures, but included the full set of
nuisance parameters in the linear model'3
giving us greater accuracy. Maternal age and
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maternal year of birth were treated as cate-
gorical variables.
We adopted a backward elimination pro-
cedure for determining a suitable model; firstly
by including all risk factors of interest-
maternal age, maternal year of birth, and
parity-in the initial model and then at each
stage excluding the most unimportant variable,
using the deviance (likelihood ratio statistic) as a
criterion for comparing nested models.'3 The
procedure terminated when all remaining risk
factors were significant. In this way the com-
peting effects of maternal age and maternal year
of birth could be assessed.
Separate analyses were carried out for an-
encephaly and for spina bifida and cranium
bifidum. For each analysis, we provide a table
of relative risk factors for the final model with
95% confidence intervals. For maternal age, the
risks are relative to the youngest age group, and
for maternal year of birth, the risks are relative
to the earliest maternal birth cohort.
Results
After 1972 anencephalic births in the Fylde
declined to zero (tables 1 and 2). Much of
this fall was due to antenatal diagnosis of
anencephaly with termination of pregnancy.
Births of babies with spina bifida and cranium
bifidum also declined after 1973 but the fall was
less than for anencephaly. However there were
fewer terminations for spina bifida and cranium
bifidum so that the underlying decline in
prevalence was greater than for anencephaly.
ANENCEPHALY
Parity (changes in deviance=0-36 on 1 df;
p=0 55) followed by maternal year of birth
(change in deviance=1-84 on 3 df; p=0-61)
were found to be unimportant and were excluded
from the logistic regression model. A strong
effect of maternal age was observed which could
not be excluded from the model (change in
deviance= 17-66 on 2 df; p<0-0001).
Table I Prevalence of neural tube defects in the Fylde of
Lancashire 1957-89
Period Total Anencephaly Spina bifida and
births cranium bifidum
Births Prevalencel
1000 births Births Prevalencel
1000 births
1957-61 18321 59 3-2 57 3-1
1962-66 20827 53 2-5 58 2-8
1967-71 19132 24 1-3 40 2-1
1972-76 15281 20 1-3 31 2-0
1977-81 14888 9 0-6 11 0-7
1982-86 16488 2 0-1 7 0-4
1987-89 11345 0 0-0 3 0 3
Table 2 Prevalence from 1977 including terminations of
pregnancy for antenatal diagnosis of neural tube defects
Period Total Anencephaly Spina bifuda and
births cranium biftdum
Births Prevalencel
1000 births Births Prevalencel
1000 births
1977-81 14888 13 0-9 11 0-7
1982-86 16488 12 0-7 13 0-8
1987-89 11345 9 0-8 8 0-7
Table 3 Maternal age and relative risk for anencephaly
Relative risk 95% Confidence interval
Maternal age:
25-29 v <25 1-921 1-134 to 3-251
¢30 v <25 2-910 1-704 to 4-967
Table 4 Maternal year of birth and relative risk for spina
bifida and cranium bifidum
Relative
risk 95% Confidence interval
Maternal year of birth:
1940-1949 v pre-1940 0-9336 0-548 to 1-590
1950-1959 v pre-1940 0 2574 0-085 to 0-783
Post 1959 v pre-1940 0-2845 0-068 to 1 191
The relative risk for mothers over 25 is nearly
double that for younger mothers (table 3), and
the relative risk increases still further for
mothers over 30, being nearly treble that of
younger mothers.
SPINA BIFIDA AND CRANIUM BIFIDUM
Parity was again the least important variable
(change in deviance=0-04 on 1 df; p=0-84) but
maternal age (change in deviance= 1 15 on 2 df;
p=0-56) was also found to be unimportant and
was excluded from the model, leaving maternal
year of birth as the only important factor
(change in deviance=7-90 on 3 df; p<0O05).
Replacing the maternal year of birth factor by a
linear trend for maternal year of birth produced
a significant change of deviance of 5-99 on 2 df
(p=0-05) and the linear trend was no longer
significant (change in deviance= 1-91 on 1 df;
p=0- 17).
It can be seen from table 4 that maternal year
of birth is a significant risk factor. The relative
risk is close to one until 1950, then declines
susbstantially. For mothers born before 1950,
the risk of spina bifida or cranium bifidum is
more than treble that for mothers born after
1950.
Discussion
The sudden significant fall in the prevalence of
anencephaly in the Fylde after 1968 was not
seen in north west England or nationally. It was
associated with increasing hardness of the
summer water in a supply which was confined
to the Fylde.2 The prevalence of spina bifida
and cranium bifidum showed a small fall that
was not significant.
After 1972-3 the prevalence of both anence-
phaly and spina bifida and cranium bifidum in
the Fylde declined again, reflecting the trend in
England and Wales.3 Further, antenatal diag-
nosis of a neural tube defect with termination of
the pregnancy, which was more successful in
reducing anencephaly, could explain only part
of the decline in prevalence, especially of spina
bifida as was found in Sheffield.' Therefore our
trends since 1972 are in accord with those found
elsewhere and the results of the cohort studies
should have general relevance.
The idea that environmental factors acting
during the mother's early life could predispose
her to produce babies with neural tube defects
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later is not new. It has been suggested that non-
specific interference with early growth and
development may affect the reproductive and/or
endocrine systems and contribute to the later
production of neural tube defects.'4 The inter-
ference could be short or long lived and
produced by many conditions, such as nutri-
tional deficiencies, severe illness, or socio-
cultural factors. Recently, a related idea has
been proposed that environmental program-
ming in fetal and infant life affects adult
degenerative disease.'5
ANENCEPHALY
We have found that the mother's year of birth
did not affect her risk of having a baby with
anencephaly. Her age did, the risk increasing in
older mothers. However, apart from a slight dip
in the proportion of mothers aged 30 years or
more between 1971 and 1977, seen both in the
Fylde (figure) and nationally, the proportion of
older mothers increased up to 1989. Therefore
the declining prevalence of anencephaly was
unlikely to be due to change in maternal age
distribution.
SPINA BIFIDA AND CRANIUM BIFIDUM
Maternal year of birth was an important risk
factor. The evidence is that the decline in risk
was sudden rather than gradual, with mothers
born after 1949 significantly less likely to have
an affected baby. In other words, fewer mothers
could be regarded as preconditioned to have a
baby with these anomalies. This is chrono-
logically compatible with the fewer recorded
births of affected babies after 1973 and suggests
that, apart from termination, the underlying
cause of the decline is to be sought in events in
the early 1950s.
Janerich suggested that the 1918-9 influenza
pandemic may have been a preconditioning
event for the epidemic of neural tube defects
which peaked in 1929L32.16 However it is not
possible to relate the current decline in spina
bifida to the pattern of influenzal infections.
For example, if the pandemics of 1957 and 1969
were preconditioning events, an increased
prevalence of spina bifida would have been
expected at a time when, in fact, it was in a
prolonged decline.
Dietary deficiencies have also been suggested
for preconditioning events. The most noticeable
general improvement in nutrition occurred in
1940 with rationing and the provision of welfare
foods for mothers and children.'7 This led to an
immediate steep fall in perinatal mortality and
improved growth of children, but we find little
change in the risk to future mothers of a baby
with spina bifida. The significant change occur-
red some 10 years later and we are unaware of
any further relevant improvement in diet then.
Searching for other possible preconditioning
events we noted that mercury was largely
abandoned in the treatment of infants in the
early 1950s. From 1948 warnings were given
that the metal could cause pink disease in
susceptible infants.'8 19 Mercury nephrosis was
also described.20 Apart from doctors' prescrip-
tions of grey powder (mercury with chalk) or
calomel for constipation and other symptoms in
infants, calomel was a constituent of many
proprietary teething powders which were
widely used. For example, it was found that
approximately 40% of the infant population of
Manchester and Salford, and also of Warwick-
shire, received them.'9 Absorption of the metal
could also occur from the use of mercurial oint-
ments for treating napkin rashes. By 1955 a
decline in pink disease and less mercury inges-
tion in infants was reported from Sheffield.2' It
became clear that mercury had caused a pro-
longed, serious, sometimes fatal illness in some
infants. In addition, abortive cases had been
common.22 Anorexia was a prominent feature
and mercury could have exerted its effect on
subsequent reproduction through a period of
malnutrition. Additionally, mercurial toxicity
could have been specific as it has been reported
to affect the germ cells of mammals.23
We suggest that administration of mercury
was a possible preconditioning event for subse-
quent spina bifida or cranium bifidum and
should be borne in mind when studying their
aetiology, although it may now be difficult to
obtain additional evidence to support the
chronological findings.
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Tuberculous hydrocephalus
As I was saying (1991;66:151), hydrocephalus occurs in a large
majority of children with severe tuberculous meningitis. The best
way of treating this hydrocephalus is uncertain and a report from
South Africa compares several possible treatments (J Schoeman and
colleagues, Developmental Medicine and Child Neurology 1991;33:
396-405). The study included 81 children aged 5 months to 8
years with severe tuberculous meningitis ofMRC stages II and III
at admission. (Stage I, early, mainly non-specific symptoms, little
or no clinical sign of meningitis, no pareses, general condition
good, fully conscious. Stage II, intermediate between I and III.
Stage III advanced, extremely ill, deeply stuporose or comatose or
with gross pareses. 1) All the children received antituberculous
treatment with four drugs; isoniazid, rifampicin, ethionamide,
and pyrazinamide. Communicating hydrocephalus was present in
63 and non-communicating in 18. Those with non-communicating
hydrocephalus were all treated early with a ventriculoperitoneal
shunt. Those with communicating hydrocephalus were allocated
randomly to one of four treatment groups: group A, no extra
treatment (n= 19), group B, weekly intrathecal hyaluronidase
(n= 19), group C, oral acetazolamide and frusemide (n= 19), and
group D, shunt surgery. Group D was discontinued after six
patients had been operated upon because the authors considered
the results of medical treatment to be 'encouraging'.
The lumbar cerebrospinal fluid pressure fell to normal over
the first month in 41% of surviving patients in group A, 71% in
group B, and 78% in group C, but mortality and morbidity were
high in all groups and unaffected by the type of treatment. The
overall mortality was 8% for stage II disease and 30% for stage III.
Of the survivors of stage III disease 66% were severely mentally
impaired (IQ<50), 27% were moderately mentally impaired (IQ
50-85), and 71% had a quadriplegia or a hemiplegia. Of stage II
disease survivors 14% were severely mentally impaired, 69%
moderately mentally impaired, and 26% had quadriplegia or
hemiplegia.
The severity of disease at presentation is the most important
factor determining outcome. This work has not shown that
treatment of the hydrocephalus does anything to help these
children. Intrathecal hyaluronidase did not seem to have harmful
effects but acetazolamide and frusemide produced dehydration in
three patients possibly associated with sagittal sinus thrombosis in
one. Of the 24 children who had a ventriculoperitoneal shunt
procedure five developed shunt dysfunction. Four of these had an
infected shunt and they all died. These authors give no compelling
reason for treating communicating hydrocephalus in tuberculous
meningitis, although they advocate treatment with acetazolamide
and frusemide. For non-communicating hydrocephalus they
recommend early shunt surgery but the data they present do not
permit an evaluation of that recommendation.
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